Notice for etranacogene dezaparvovec (CSL Behring Australia Pty Ltd)
Active ingredients
etranacogene dezaparvovec
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
For the treatment of haemophilia B
Therapeutic area
Haematology